PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1519302
PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1519302
The GABA supplements market is poised for significant expansion, with projections indicating it will grow from $45.31 million in 2024 to $69.32 million by 2031, reflecting a CAGR of 6%. This growth highlights the increasing consumer awareness and demand for dietary supplements that aid relaxation, enhance sleep quality, and reduce anxiety. Capsules are expected to dominate the market in terms of revenue generation, showing substantial growth prospects in the coming years.
Key Factors Driving Market Growth
Several factors are driving the growth of the GABA supplements market. These supplements offer numerous health benefits, such as promoting brain relaxation, lowering stress levels, improving sleep quality, and reducing anxiety and hormonal irritability. In today's fast-paced environment, where stress, anxiety, and sleep disorders are common, these benefits are particularly valuable.
According to the Sleep Foundation, a significant number of adults globally suffer from insomnia, with chronic insomnia affecting a large portion of the population. Countries like Japan, the United States, the United Kingdom, and South Korea report high levels of sleep dissatisfaction, creating a significant opportunity for GABA supplements known for their relaxation and sleep-enhancing properties.
Impact of Covid-19 on Mental Health
The Covid-19 pandemic has significantly impacted mental health worldwide, leading to a marked increase in anxiety and depression. This surge has driven the demand for dietary supplements that promote relaxation and reduce anxiety. GABA supplements, known for supporting neurotransmitter function, are gaining popularity as effective solutions for these mental health concerns.
Addressing PMDD and Hypertension
Premenstrual dysphoric disorder (PMDD) affects many women, causing anxiety, depression, mood swings, and irritability. GABA supplements can help alleviate these symptoms, making them an attractive option for those seeking mental wellness and reduced inflammation.
Hypertension is another growing concern globally, with many adults affected. Studies indicate that GABA supplements can significantly lower blood pressure, offering a potential dietary solution for managing hypertension.
Supporting Underlying Medical Conditions
Individuals with conditions such as Parkinson's disease, hyperactivity disorder, and seizure disorders may have lower GABA levels. In these cases, GABA supplements can provide additional support by inducing calming effects and reducing anxiety.
Regional Market Insights
North America
North America is a leading market for GABA supplements, driven by high levels of chronic stress and anxiety and a significant portion of the population experiencing sleep-related issues.
United States
Anxiety disorders are among the most common mental health issues in the United States, affecting millions of adults annually. Many individuals prefer dietary supplements over traditional treatments to manage their anxiety, presenting a growth opportunity for GABA supplements.